Seagen Inc.
Glycan-interacting compounds and methods of use

Last updated:

Abstract:

Methods of treating cancer are provided that include administering glycan-interacting antibodies. Included are anti-sialyl Tn antigen antibodies and related compositions and formulations suitable to achieve desirable bioactivity, bioavailability, and toxicity levels.

Status:
Grant
Type:

Utility

Filling date:

2 Mar 2018

Issue date:

22 Feb 2022